Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis-Reference-Cited by-同舟云学术

Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis

Published:2020-09 Issue: Volume:150 Page:195-200
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Mendez Lucas C.,Martell Kevin^ORCID,Warner Andrew,Tseng Chia-Lin,Chung Hans,Loblaw Andrew^ORCID,Rodrigues George B.,Morton Gerard

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference28 articles.

1. Androgen receptor signaling regulates DNA repair in prostate cancers;Polkinghorn;Cancer Discov,2013

2. Androgen receptor upregulation mediates radioresistance after ionizing radiation;Spratt;Cancer Res,2015

3. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

4. High–intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy;Pickles;Brachytherapy,2017

5. Brachytherapy for intermediate-risk prostate cancer, androgen deprivation, and the risk of death;Pickles;Int J Radiat Oncol,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost;Strahlentherapie und Onkologie;2024-06-03

2. Acute toxicity outcomes from salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after prior radiotherapy;Journal of Contemporary Brachytherapy;2024

3. Combined radiotherapy and hormone therapy in unfavorable intermediate risk prostate cancer;Cancer Urology;2023-05-13

4. GEC-ESTRO ACROP prostate brachytherapy guidelines;Radiotherapy and Oncology;2022-02

5. Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer;Journal of Contemporary Brachytherapy;2022